Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Myeloid, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma 4Leukemia, Prolymphocytic 3Congenital Abnormalities 3Burkitt Lymphoma 3Blast Crisis 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Wilms Tumor 1Tumor Lysis Syndrome 1Thrombocytopenia 1

Interventions

Filgrastim 2Carboplatin 2becatecarin 1alvocidib 1Topotecan 1Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Retinoblastoma × alvocidib × Lymphoid × Clear all
NCT00012181 2013-07-02

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSGenitourinaryLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡